Literature DB >> 6976416

Human monoclonal anti-keyhole limpet hemocyanin antibody-secreting hybridoma produced from peripheral blood B lymphocytes of a keyhole limpet hemocyanin-immune individual.

H C Lane, J H Shelhamer, H S Mostowski, A S Fauci.   

Abstract

A human IgMk monoclonal antibody, 2F7, of predetermined specificity, has been produced by the fusion of human peripheral blood lymphocytes with the nonsecreting mouse myeloma line SP-1. The heterohybridoma has remained stable for over 8 mo, with culture supernatants containing up to 30 micrograms/ml of specific IgM. The antibody has been shown to be capable of inducing a blastogenic response in the absence of antigen in the peripheral blood lymphocytes of normal subjects immune to the antigen. The ability to choose an antigen, immunize a human subject to that antigen, and then use the peripheral blood lymphocytes from that subject to produce antigen-specific human monoclonal antibodies should be of great value in a wide variety of investigative, diagnostic, and therapeutic endeavors.U

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6976416      PMCID: PMC2186568          DOI: 10.1084/jem.155.1.333

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  13 in total

1.  Continuous cultures of fused cells secreting antibody of predefined specificity.

Authors:  G Köhler; C Milstein
Journal:  Nature       Date:  1975-08-07       Impact factor: 49.962

2.  Immunoglobulin production by a human-mouse somatic cell hybrid.

Authors:  J Schwaber
Journal:  Exp Cell Res       Date:  1975-07       Impact factor: 3.905

3.  Characterization of a circulating subpopulation of spontaneous antitetanus toxoid antibody producing B cells following in vivo booster immunization.

Authors:  R H Stevens; E Macy; C Morrow; A Saxon
Journal:  J Immunol       Date:  1979-06       Impact factor: 5.422

4.  Rescue of immunoglobulin secretion from human neoplastic lymphoid cells by somatic cell hybridization.

Authors:  R Levy; J Dilley
Journal:  Proc Natl Acad Sci U S A       Date:  1978-05       Impact factor: 11.205

5.  Production of human hybridomas secreting antibodies to measles virus.

Authors:  C M Croce; A Linnenbach; W Hall; Z Steplewski; H Koprowski
Journal:  Nature       Date:  1980-12-04       Impact factor: 49.962

6.  Alternate-day prednisone therapy and human lymphocyte subpopulations.

Authors:  A S Fauci; D C Dale
Journal:  J Clin Invest       Date:  1975-01       Impact factor: 14.808

7.  Characterization of a monoclonal antibody that defines an immunoregulatory T cell subset for immunoglobulin synthesis in humans.

Authors:  B F Haynes; D L Mann; M E Hemler; J A Schroer; J H Shelhamer; G S Eisenbarth; J L Strominger; C A Thomas; H S Mostowski; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1980-05       Impact factor: 11.205

8.  Human-human hybridomas producing monoclonal antibodies of predefined antigenic specificity.

Authors:  L Olsson; H S Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

9.  Human monoclonal antibody against Forssman antigen.

Authors:  R Nowinski; C Berglund; J Lane; M Lostrom; I Bernstein; W Young; S I Hakomori; L Hill; M Cooney
Journal:  Science       Date:  1980-10-31       Impact factor: 47.728

10.  Generation of human monoclonal antibodies reactive with human mammary carcinoma cells.

Authors:  J Schlom; D Wunderlich; Y A Teramoto
Journal:  Proc Natl Acad Sci U S A       Date:  1980-11       Impact factor: 11.205

View more
  17 in total

Review 1.  Mining human antibody repertoires.

Authors:  Roger R Beerli; Christoph Rader
Journal:  MAbs       Date:  2010-07-01       Impact factor: 5.857

2.  Antibody immunity and natural resistance to cryptococcosis.

Authors:  N Trevijano-Contador; L Pirofski
Journal:  Curr Trop Med Rep       Date:  2019-04-04

3.  Production of human monoclonal IgG and IgM antibodies with anti-D (rhesus) specificity using heterohybridomas.

Authors:  K M Thompson; M D Melamed; K Eagle; B D Gorick; T Gibson; A M Holburn; N C Hughes-Jones
Journal:  Immunology       Date:  1986-05       Impact factor: 7.397

4.  Generating human monoclonal antibodies.

Authors:  A M Neville; P A Edwards; M J O'Hare
Journal:  Med Oncol Tumor Pharmacother       Date:  1984

5.  Construction and testing of mouse--human heteromyelomas for human monoclonal antibody production.

Authors:  N N Teng; K S Lam; F Calvo Riera; H S Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  1983-12       Impact factor: 11.205

6.  Efficient generation in vitro, from human peripheral blood cells, of monoclonal Epstein-Barr virus transformants producing specific antibody to a variety of antigens without prior deliberate immunization.

Authors:  L Winger; C Winger; P Shastry; A Russell; M Longenecker
Journal:  Proc Natl Acad Sci U S A       Date:  1983-07       Impact factor: 11.205

7.  Generation of human monoclonal antibodies reactive with cellular antigens.

Authors:  R J Cote; D M Morrissey; A N Houghton; E J Beattie; H F Oettgen; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1983-04       Impact factor: 11.205

8.  Characterization of human hybridomas secreting antibody to tetanus toxoid.

Authors:  J W Larrick; K E Truitt; A A Raubitschek; G Senyk; J C Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

Review 9.  Human monoclonal antibodies.

Authors:  S P Cole; B G Campling; T Atlaw; D Kozbor; J C Roder
Journal:  Mol Cell Biochem       Date:  1984-06       Impact factor: 3.396

10.  Protective human hybridoma antibody to tetanus toxin.

Authors:  F Gigliotti; R A Insel
Journal:  J Clin Invest       Date:  1982-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.